AR018297A1 - Uso de un antagonista d1/d5 para la manufactura de un medicamento para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenesdisociativos, desordenes al comer, desordenes de control de impulso y autismo - Google Patents
Uso de un antagonista d1/d5 para la manufactura de un medicamento para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenesdisociativos, desordenes al comer, desordenes de control de impulso y autismoInfo
- Publication number
- AR018297A1 AR018297A1 ARP990100860A ARP990100860A AR018297A1 AR 018297 A1 AR018297 A1 AR 018297A1 AR P990100860 A ARP990100860 A AR P990100860A AR P990100860 A ARP990100860 A AR P990100860A AR 018297 A1 AR018297 A1 AR 018297A1
- Authority
- AR
- Argentina
- Prior art keywords
- disorders
- antagonist
- manufacture
- autism
- distociative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3320598A | 1998-03-02 | 1998-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018297A1 true AR018297A1 (es) | 2001-11-14 |
Family
ID=21869083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100860A AR018297A1 (es) | 1998-03-02 | 1999-03-01 | Uso de un antagonista d1/d5 para la manufactura de un medicamento para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenesdisociativos, desordenes al comer, desordenes de control de impulso y autismo |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1058551A1 (sk) |
| JP (1) | JP2002505291A (sk) |
| KR (1) | KR20010041477A (sk) |
| CN (1) | CN1291893A (sk) |
| AR (1) | AR018297A1 (sk) |
| AU (1) | AU2778099A (sk) |
| BR (1) | BR9908392A (sk) |
| CA (1) | CA2322201A1 (sk) |
| CO (1) | CO4910136A1 (sk) |
| HU (1) | HUP0101057A3 (sk) |
| IL (1) | IL137715A0 (sk) |
| NO (1) | NO20004363L (sk) |
| PE (1) | PE20000333A1 (sk) |
| SK (1) | SK12962000A3 (sk) |
| WO (1) | WO1999044615A1 (sk) |
| ZA (1) | ZA991638B (sk) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| RU2374245C1 (ru) | 2008-08-22 | 2009-11-27 | Андрей Александрович Иващенко | Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство |
| PT2872145T (pt) * | 2012-07-12 | 2022-05-26 | Emalex Biosciences Inc | Benzazepinas fundidas para o tratamento da síndrome de tourette |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
| EP1043980A2 (en) * | 1997-10-28 | 2000-10-18 | Schering Corporation | Method of reducing craving in mammals |
-
1999
- 1999-03-01 BR BR9908392-2A patent/BR9908392A/pt not_active IP Right Cessation
- 1999-03-01 PE PE1999000169A patent/PE20000333A1/es not_active Application Discontinuation
- 1999-03-01 AU AU27780/99A patent/AU2778099A/en not_active Abandoned
- 1999-03-01 HU HU0101057A patent/HUP0101057A3/hu unknown
- 1999-03-01 IL IL13771599A patent/IL137715A0/xx unknown
- 1999-03-01 CO CO99012525A patent/CO4910136A1/es unknown
- 1999-03-01 CN CN99803496A patent/CN1291893A/zh active Pending
- 1999-03-01 EP EP99908318A patent/EP1058551A1/en not_active Withdrawn
- 1999-03-01 CA CA002322201A patent/CA2322201A1/en not_active Abandoned
- 1999-03-01 WO PCT/US1999/003721 patent/WO1999044615A1/en not_active Application Discontinuation
- 1999-03-01 JP JP2000534217A patent/JP2002505291A/ja not_active Withdrawn
- 1999-03-01 KR KR1020007009634A patent/KR20010041477A/ko not_active Application Discontinuation
- 1999-03-01 ZA ZA9901638A patent/ZA991638B/xx unknown
- 1999-03-01 AR ARP990100860A patent/AR018297A1/es unknown
- 1999-03-01 SK SK1296-2000A patent/SK12962000A3/sk unknown
-
2000
- 2000-09-01 NO NO20004363A patent/NO20004363L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA991638B (en) | 1999-09-01 |
| WO1999044615A1 (en) | 1999-09-10 |
| HUP0101057A3 (en) | 2001-09-28 |
| AU2778099A (en) | 1999-09-20 |
| PE20000333A1 (es) | 2000-05-13 |
| IL137715A0 (en) | 2001-10-31 |
| BR9908392A (pt) | 2000-10-31 |
| CA2322201A1 (en) | 1999-09-10 |
| JP2002505291A (ja) | 2002-02-19 |
| HUP0101057A2 (hu) | 2001-08-28 |
| CO4910136A1 (es) | 2000-04-24 |
| NO20004363L (no) | 2000-10-31 |
| KR20010041477A (ko) | 2001-05-25 |
| NO20004363D0 (no) | 2000-09-01 |
| SK12962000A3 (sk) | 2001-08-06 |
| EP1058551A1 (en) | 2000-12-13 |
| CN1291893A (zh) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| ATE217192T1 (de) | Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen | |
| BR0015188A (pt) | Composições farmacêuticas | |
| ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
| TR200202737T2 (tr) | Aktif katkı maddeleri ihtiva eden şekerleme ürünleri. | |
| MX9205443A (es) | 4-alcoxi-pirimidinas sustituidas, procedimientos para su preparacion, agentes que las contienen, y su utilizacion como agentes plaguicidas. | |
| UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
| AR028959A1 (es) | Uso de rapamicina para la manufactura de un medicamento para tratar enfermedades cardiovasculares | |
| WO2003005960A3 (en) | Novel bicyclic and tricyclic cannabinoids | |
| ECSP045025A (es) | Combinación de opioides seleccionados con antagonistas muscarnicos para el tratamiento de la incontinencia urinaria | |
| EA200200207A1 (ru) | Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы | |
| ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
| ATE220290T1 (de) | Wirkstoffhaltige aromatische copolyester | |
| AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
| ES2172171T3 (es) | Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles. | |
| IT1269185B (it) | Associazione dotata di effetto sinergico che ha un effetto antagonista dei recettori nk1 e nk2 | |
| RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
| EE05211B1 (et) | Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluhirete, kohanemishirete v?i segatpi rev-depressiivsete hirete raviks v?i vltimiseks kasulike ravimite valmistamiseks | |
| AR018297A1 (es) | Uso de un antagonista d1/d5 para la manufactura de un medicamento para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenesdisociativos, desordenes al comer, desordenes de control de impulso y autismo | |
| TNSN96016A1 (fr) | Utilisation de phenylcyclohexylcarboxamides | |
| MXPA02012894A (es) | Catecoles nitrados substituidos, su uso en el tratamiento de algunos trastornos del sistema nervioso central y periferico y composiciones farmaceuticas que los contienen. | |
| DE68905973D1 (de) | Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen. | |
| AR018376A1 (es) | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento | |
| TW371630B (en) | Deodorizer | |
| DE60107444D1 (de) | Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |